Bioventix (LSE:BVXP) Interest Expense

: £0.00 Mil (TTM As of Dec. 2023)

View and export this data going back to 2014. Start your Free Trial

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Bioventix's interest expense for the six months ended in Dec. 2023 was £ 0.00 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2023 was £0.00 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Bioventix's Operating Income for the six months ended in Dec. 2023 was £ 5.16 Mil. Bioventix's Interest Expense for the six months ended in Dec. 2023 was £ 0.00 Mil. Bioventix has no long-term debt ⁽¹⁾. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

(1) Note: An indication of "no long-term debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

Bioventix Interest Expense Historical Data

The historical data trend for Bioventix's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bioventix Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Interest Expense

Bioventix Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Interest Expense																-	-	-	-	-

Bioventix Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was £0.00 Mil.

Bioventix (LSE:BVXP) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Bioventix's Interest Expense for the six months ended in Dec. 2023 was £0.00 Mil. Its Operating Income for the six months ended in Dec. 2023 was £5.16 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Dec. 2023 was £0.00 Mil.

Bioventix's Interest Coverage for the quarter that ended in Dec. 2023 is calculated as

Bioventix had no long-term debt ⁽¹⁾.

The higher the ratio, the stronger the company's financial strength is.

Good Sign:

Bioventix PLC has no debt.

Bioventix (LSE:BVXP) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bioventix PLC (LSE:BVXP) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

BVXP.GB:UK 51B:Germany

Address

East Street, 7 Romans Business Park, Farnham, Surrey, GBR, GU9 7SX

Website

http://www.bioventix.com

Bioventix PLC is a biotechnology company based in the United Kingdom. It specializes in the creation and supply of high-affinity sheep monoclonal antibodies and clinical diagnostics and drug abuse testing. The company's portfolio of products includes drugs that are applicable in the areas of cardiology, fertility, infectious diseases, Thyroid, and vitamin D disorder among others.

Bioventix (LSE:BVXP) Headlines

No Headlines